You have 9 free searches left this month | for more free features.

MGMT deficient,

Showing 1 - 25 of 930

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adenocarcinoma - GEJ, Cancer of Esophagus Trial in Cambridge (Temozolomide, Temozolomide 50mg/m2/day, Temozolomide 3 month)

Recruiting
  • Adenocarcinoma - GEJ
  • Cancer of Esophagus
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Oct 6, 2021

Colorectal Tumors, Microsatellite Instability Trial in Milano, Rozzano (temozolomide (induction),, pembrolizumab (treatment))

Recruiting
  • Colorectal Neoplasms
  • Microsatellite Instability
  • temozolomide (induction),
  • pembrolizumab (treatment)
  • Milano, Italy
  • +3 more
Sep 28, 2022

Metastatic Colorectal Cancer Trial in Milan (Temozolomide, Nivolumab, Ipilimumab)

Completed
  • Metastatic Colorectal Cancer
  • Milan, MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022

Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))

Active, not recruiting
  • Glioblastoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 30, 2023

MGMT-Unmethylated Glioblastoma Trial (Etoposide Plus Cisplatin)

Not yet recruiting
  • MGMT-Unmethylated Glioblastoma
  • Etoposide Plus Cisplatin
  • (no location specified)
Jan 12, 2023

Glioblastoma, Glioma, Malignant Trial in Durham (MT-201-GBM monocyte vaccine)

Not yet recruiting
  • Glioblastoma
  • Glioma, Malignant
  • MT-201-GBM monocyte vaccine
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University M
May 25, 2022

Glioblastoma, Brain Tumor, Cannabis Trial in United Kingdom (Sativex, Temozolomide, Sativex-matched )

Not yet recruiting
  • Glioblastoma
  • +3 more
  • Belfast, United Kingdom
  • +14 more
Nov 29, 2022

Adolescent Idiopathic Scoliosis, Neuromuscular Scoliosis, Perioperative/Postoperative Complications Trial in New York (Oral

Not yet recruiting
  • Adolescent Idiopathic Scoliosis
  • +6 more
  • Oral ferrous sulfate
  • Oral placebo tablet
  • New York, New York
    Columbia University Medical Center
Sep 12, 2023

Colorectal Cancer Trial in New Haven (Temozolomide + Olaparib)

Active, not recruiting
  • Colorectal Cancer
  • Temozolomide + Olaparib
  • New Haven, Connecticut
    Yale New Haven Hospital
Aug 17, 2022

Metastatic Colorectal Cancer Trial in Milan (Bevacizumab, Irinotecan, Leucovorin)

Recruiting
  • Metastatic Colorectal Cancer
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022

Advanced Glioblastoma, Metastatic Melanoma in the CNS, MGMT-Unmethylated Glioblastoma Trial in Ramat Gan (Crizanlizumab-Tmca 10

Not yet recruiting
  • Advanced Glioblastoma
  • +2 more
  • Crizanlizumab-Tmca 10 MG/1 ML Intravenous Solution [ADAKVEO]
  • Nivolumab 10 MG/1 ML Intravenous Solution [OPDIVO]
  • Ramat Gan, Israel
    Sheba medical center
Jun 11, 2023

Brain Cancer Trial in Worldwide (Nivolumab, Temozolomide, Radiotherapy)

Completed
  • Brain Cancer
  • Birmingham, Alabama
  • +124 more
Mar 16, 2022

Glioblastoma Trial in Gainesville (Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells)

Not yet recruiting
  • Glioblastoma
  • Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells
  • Gainesville, Florida
    University of Florida Health
Jul 29, 2022

Adult Glioblastoma Trial in Gainesville (Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane

Recruiting
  • Adult Glioblastoma
  • Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane protein (LAMP) mRNA loaded DOTAP liposome vaccine administered intravenously (RNA loaded lipid particles, RNA-LPs)
  • Gainesville, Florida
    UF Health
Aug 30, 2022

Glioblastoma Trial (Azeliragon)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Aug 3, 2023

Head and Neck Squamous Cell Carcinoma, Malignant Solid Tumor Trial in Houston (Alisertib, Pembrolizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Malignant Solid Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

CD55-deficient Protein-losing Enteropathy, CHAPLE Trial in Bethesda, Pathum Wan, Istanbul (Pozelimab)

Active, not recruiting
  • CD55-deficient Protein-losing Enteropathy
  • CHAPLE
  • Bethesda, Maryland
  • +2 more
Nov 8, 2022

Guided Bone Regeneration Trial in Cairo (Double layer technique)

Completed
  • Guided Bone Regeneration
  • Double layer technique
  • Cairo, Egypt
    Ain shams university , faculty of dentistry
Nov 15, 2023

Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,

Not yet recruiting
  • Glioblastoma Multiforme
  • +3 more
  • P140K-MGMT
  • +5 more
  • Bethesda, Maryland
  • +1 more
Jul 4, 2022

Neuroendocrine Tumors Trial in France (Oxaliplatin-based chemo, Alkylating-based chemo)

Active, not recruiting
  • Neuroendocrine Tumors
  • Oxaliplatin-based chemotherapy
  • Alkylating-based chemotherapy
  • Amiens, France
  • +18 more
Mar 15, 2022

Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)

Not yet recruiting
  • Ovarian Cancer
  • Olaparib tablet
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Nov 1, 2023

MGMT-unmethylated Glioblastoma (GBM), GBM Trial in New York (Nivolumab, Ipilimumab, Radiation Therapy (RT))

Completed
  • MGMT-unmethylated Glioblastoma (GBM)
  • GBM
  • New York, New York
    New York University School of Medicine
Jun 30, 2022

Dry Eye Trial in Gallarate (Rexon-Eye)

Completed
  • Dry Eye
  • Rexon-Eye
  • Gallarate, VA, Italy
    Centro Oculistico Borroni
Nov 3, 2023

Rectal Cancer Trial in Milan (External-beam radiation, Capecitabine, Temozolomide)

Recruiting
  • Rectal Cancer
  • External-beam radiation
  • +2 more
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Jan 25, 2022

Glioblastoma Multiforme Trial in Canada, United States (drug, radiation, device)

Recruiting
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +17 more
Apr 1, 2022